A Comparative Assessment of the Pathogenic Potential of Newly Discovered Henipaviruses
Pathogens · 2024
DOI: 10.3390/pathogens13070587 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens, 2024. Verfasst von Kristina Meier und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Virology, Immunology and Microbiology, Chobanian & Avedisian School of Medicine, Boston University, Boston, MA 02118, USA. Hauptthemen laut MEDLINE: Henipavirus Infections, Henipavirus, Chiroptera. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gates Foundation, Howard Hughes Medical Institute, Bill & Melinda Gates Foundation.
Abstract (Originalsprache)
Recent advances in high-throughput sequencing technologies have led to the discovery of a plethora of previously unknown viruses in animal samples. Some of these newly detected viruses are closely related to human pathogens. A prime example are the henipaviruses. Both Nipah (NiV) and Hendra virus (HeV) cause severe disease in humans. Henipaviruses are of zoonotic origin, and animal hosts, including intermediate hosts, play a critical role in viral transmission to humans. The natural reservoir hosts of NiV and HeV seem to be restricted to a few fruit bat species of the Pteropus genus in distinct geographic areas. However, the recent discovery of novel henipa- and henipa-like viruses suggests that these viruses are far more widespread than was originally thought. To date, these new viruses have been found in a wide range of animal hosts, including bats, shrews, and rodents in Asia, Africa, Europe, and South America. Since these viruses are closely related to human pathogens, it is important to learn whether they pose a threat to human health. In this article, we summarize what is known about the newly discovered henipaviruses, highlight differences to NiV and HeV, and discuss their pathogenic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Virology, Immunology and Microbiology, Chobanian & Avedisian School of Medicine, Boston University, Boston, MA 02118, USA.
- National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02218, USA.
ORCID-Profile: Kristina Meier, Judith Olejnik, Adam J Hume, Elke Mühlberger
Förderung
- Gates Foundation
- Howard Hughes Medical Institute
- Bill & Melinda Gates Foundation
- Emerging Pathogens Initiative of the Howard Hughes Medical Institute
Zitieren
APA
Meier, K., Olejnik, J., Hume, A. J., & Mühlberger, E. (2024). A Comparative Assessment of the Pathogenic Potential of Newly Discovered Henipaviruses. Pathogens. https://doi.org/10.3390/pathogens13070587
Vancouver
Meier K, Olejnik J, Hume AJ, Mühlberger E. A Comparative Assessment of the Pathogenic Potential of Newly Discovered Henipaviruses. Pathogens. 2024. doi:10.3390/pathogens13070587
BibTeX
@article{Meier2024,
author = {Meier, Kristina and Olejnik, Judith and Hume, Adam J and Mühlberger, Elke},
title = {A Comparative Assessment of the Pathogenic Potential of Newly Discovered Henipaviruses},
journal = {Pathogens},
year = {2024},
doi = {10.3390/pathogens13070587}
}
EUVIMED